Genoux, Béatrice
Guillaume, Sébastien
Buis, Claire
Bakouline, Marine Chobert
Bosson, Jean-Luc
Bétry, Cécile https://orcid.org/0000-0001-6729-2704
Funding for this research was provided by:
the Agiradom association
Article History
Received: 2 June 2026
Accepted: 9 September 2026
First Online: 14 September 2026
Declarations
Ethics approval and consent to participate: The APAMAdom study was conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its later amendments, as well as Good Clinical Practice guidelines (ICH E6). The study protocol was approved by a French ethics committee for the protection of individuals (CPP Sud-Ouest et Outre-Mer II, Toulouse; N° ID-RCB: 2022-A00749-34). This study was registered on ClinicalTrials.gov (NCT05803707). The study protocol (in French) is available from the corresponding author upon reasonable request. All participants provided written informed consent prior to enrollment.
Consent for publication: Not applicable.
Competing interests: CB reports honoraria from Agiradom, and hospitality fees from Agiradom. The other authors declare no competing interests.